期刊文献+

聚乙二醇化促胰岛素分泌肽类似物的修饰条件优化 被引量:2

Modified Condition Optimization of the Pegylation of Glucagon-like Peptide-1
下载PDF
导出
摘要 用化学合成法获得C末端氨基酸为半胱氨酸的Byetta类似物(ByC39),再采用分子量为40 kDa的马来酰亚胺活化单甲氧基聚乙二醇(mPEG-mal-40kDa)对ByC39的半胱氨酸巯基进行定点修饰,修饰产物通过阳离子交换层析和反向层析纯化获得。在已建立的定点修饰反应和分离纯化工艺基础上,通过改变反应条件中修饰pH值、修饰缓冲体系,以及修饰保护剂等因素来得到优化修饰条件:pH值为6.5的CH3COONa-CH3COOH缓冲液,保护剂为2.0mmol/L Lys和5.0 mmol/L EDTA,mPEG-mal-40 kDa/ByC39摩尔比3∶1,25℃反应4 h;经SDSPAGE和RP-HPLC检测,可知提高了修饰率以及增加了修饰产物的稳定性;最后加入TFA终止反应。 Obtained by chemical synthesis, the C-terminal amino acid is cysteine analogue Byetta (ByC39). And then using a molecular weight of 40kDa maleimide-activated monomethoxy-polyethy- lene glycol (mPEG-mal-40kDa) on ByC39 sentinel cysteine ?? thiol modification, modification prod- uct is purified by cation exchange chromatography and reverse chromatography to obtain. In the estab- lished point modification reaction and separation and purification process, based on the reaction condi- tions modified by changing pH, buffer system modification, and modification to optimize protection a- gents factors modified conditions: pH = 6.5 buffer of CH3 COONa-CH3 COOH, the protecting agent is2.0 mmol/L Lys and 5.0 mmot/L EDTA, mPEG-mal-40kDa/ByC39 reaction molar ratio 3: 1, 25℃ for 4 h. SDS-PAGE and RP-HPLC detection shows that the rate of modification and the addition modi- fied the stability of the product increase. TFA was added to terminate the reaction.
出处 《重庆理工大学学报(自然科学)》 CAS 2014年第2期45-48,共4页 Journal of Chongqing University of Technology:Natural Science
基金 国家重大新药创新"十一五"候选药物项目(2009ZX09103-6837)
关键词 促胰岛素分泌肽 聚乙二醇 修饰条件 glucogan-like peptide-1 polyethylene glycol modified conditions
  • 相关文献

参考文献12

  • 1Kieffer T J. Gastro-intestinal hormones GLP and GLP-1 [ J ]. Ann Endocrinol,2004 ,65 ( 1 ) : 13 - 21. 被引量:1
  • 2Holst J J. Glucagon-like peptide 1 (GLP-1) :an intestinal hormone, signalling nutritional abundance, with an unusu- al therapeutic potentian [ J ]. Trends Endocrinol Metab, 1999,10 (6) : 229 - 235. 被引量:1
  • 3McDannell M E. Combination therapy with new targets in type 2 diabetes :a review of available agents with a focus on pre-exercise adjustment [ J ]. J Cardiopulm Rehabil Prev ,2007 ,27 : 193 - 201. 被引量:1
  • 4Abuchowski A, Van Es T, Palczuk N C, et al. Aheration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol [ J ]. J Biol Chem 1977,252 ( 11 ) : 3578 - 3581. 被引量:1
  • 5Yeionses F M, Pasut G. PEGylation, successful approach to drug delivery [ J ]. Drug D iscov Today,2005,10 (21 ) : 1451 - 1458. 被引量:1
  • 6吴洁,刘景晶,胡卓逸.蛋白质药物的聚乙二醇修饰[J].药学进展,2002,26(3):146-151. 被引量:18
  • 7Koherman O G,Kim D D,Shen L,et al. Pharmacokinet- ics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus [ J ]. Am J Health Syst Pharm ,2005 ,62 : 173 - 181. 被引量:1
  • 8Elliott R M, Morgan L M, Tredger J A, et al. Glueagon- like peptide-1 (7 -36) amide and glucose dependent in- sulinotropie polypeptide secretion in response to nutrient ingestion in man:acute post prandial and 24h secretion patterns[ J]. J Endocrinol, 1993,138( 1 ) :159 - 166. 被引量:1
  • 9孙玉昆,伍登熙,朱志勇,等.促胰岛素分泌肽衍生物..中国:1363559[P].2002-08-14. 被引量:4
  • 10Eng J, Kleinman W A, Singh I, et al. Isolation and char- acterization of exendin - 4, an exendin - 3 analogue, from Helodenna suspeetum venom:further evidence for an ex- endin receptor on dispenscd acini from guinea pig pan- creas [ J ]. Biol Chen, 1992 ( 11 ) :7402 - 7406. 被引量:1

二级参考文献1

共引文献20

同被引文献15

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部